P Hersey
Overview
Explore the profile of P Hersey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2894
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mhaidat N, Zhang X, Allen J, Avery-Kiejda K, Scott R, Hersey P
Br J Cancer
. 2024 Nov;
131(12):1947.
PMID: 39558065
No abstract available.
2.
Owen C, Shoushtari A, Chauhan D, Palmieri D, Lee B, Rohaan M, et al.
Ann Oncol
. 2020 May;
31(8):1075-1082.
PMID: 32387454
Background: Anti-programmed cell death protein 1 (PD-1) antibodies (PD1) prolong recurrence-free survival in high-risk resected melanoma; however, approximately 25%-30% of patients recur within 1 year. This study describes the pattern...
3.
Hamid O, Robert C, Daud A, Hodi F, Hwu W, Kefford R, et al.
Ann Oncol
. 2019 Feb;
30(4):582-588.
PMID: 30715153
Background: Pembrolizumab demonstrated robust antitumor activity and safety in the phase Ib KEYNOTE-001 study (NCT01295827) of advanced melanoma. Five-year outcomes in all patients and treatment-naive patients are reported herein. Patients...
4.
Jiang C, Croft A, Tseng H, Guo S, Jin L, Hersey P, et al.
Oncogene
. 2016 Jun;
35(46):6044.
PMID: 27345411
No abstract available.
5.
Hersey P, Gibb S, Thomas S
Anaesthesia
. 2015 Nov;
70(7):888-9.
PMID: 26580264
No abstract available.
6.
Hersey P, Bolhuis R
Immunol Today
. 2014 Oct;
8(7-8):233-9.
PMID: 25290436
The receptors involved in apparently nonspecific, MHC- unrestricted effector cell-target cell interaction and lysis continue to raise controversy. They bind to distinct ligands on their target cells and activate diverse...
7.
Jiang C, Croft A, Tseng H, Guo S, Jin L, Hersey P, et al.
Oncogene
. 2013 Jun;
33(20):2577-88.
PMID: 23770856
Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation...
8.
Lai F, Guo S, Jin L, Jiang C, Wang C, Croft A, et al.
Cell Death Dis
. 2013 Jun;
4:e655.
PMID: 23744355
Past studies have shown that histone deacetylase (HDAC) and mutant BRAF (v-Raf murine sarcoma viral oncogene homolog B1) inhibitors synergistically kill melanoma cells with activating mutations in BRAF. However, the...
9.
Tay K, Jin L, Tseng H, Jiang C, Ye Y, Thorne R, et al.
Cell Death Dis
. 2012 Jun;
3:e337.
PMID: 22739989
Endoplasmic reticulum (ER) stress triggers apoptosis by activating Bim in diverse types of cells, which involves dephosphorylation of Bim(EL) by protein phosphatase 2A (PP2A). However, melanoma cells are largely resistant...
10.
Dong L, Jiang C, Thorne R, Croft A, Yang F, Liu H, et al.
Oncogene
. 2011 Mar;
30(34):3716-26.
PMID: 21423203
Past studies have shown that upregulation of the anti-apoptotic Bcl-2 family protein Mcl-1 is a major adaptive mechanism of melanoma cells to endoplasmic reticulum (ER) stress, and has an important...